m+Medelevator.RU
← Поиск публикаций
IBRO neuroscience reports · 2026

The ketogenic diet ameliorates behavioral abnormalities in a PTZ-induced zebrafish larvae model via modulating neurotransmitter balance.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Yang Xue, Lin Jia, Zhang Qi, Xia Yuheng, Zhou Shuizhen, Wang Yi, Li Qiang, Yu Lifei

Аннотация

PURPOSE: The ketogenic diet (KD) is a well-established therapy for drug-resistant epilepsy, reducing seizure burden in children and improving cognition in epileptic encephalopathy patients, but its underlying mechanisms remain incompletely understood. This study aimed to establish a translational zebrafish model to investigate KD's anti-epileptic potential and mechanisms, focusing on neurotransmitter homeostasis.

METHOD: Acute epilepsy was induced in 7-day post-fertilization (dpf) zebrafish larvae (n = 24/group, randomly assigned) using pentylenetetrazol (PTZ), a selective GABA-A receptor antagonist. KD was administered to the treatment group, with behavioral assays (locomotor activity, thigmotaxis), electroencephalographic (EEG) recordings, and high-performance liquid chromatography (HPLC) for neurotransmitter quantification. Statistics were analyzed via two-way ANOVA/Tukey's test or Student's t-test.

RESULTS: Results showed KD significantly ameliorated PTZ-induced epileptiform behaviors (prolonged seizure latency, reduced stage-specific duration), attenuated EEG multi-peak discharges, increased inhibitory neurotransmitters (GABA, glycine, taurine), and reversed PTZ-induced excitatory-inhibitory neurotransmitter imbalance (e.g., Glu/GABA, Gln/Tau ratios).

CONCLUSION: We established a PTZ-induced amphibian epilepsy model with KD intervention. KD exerts anti-epileptic effects, likely mediated partially by rebalancing central nervous system neurotransmitter homeostasis, providing a valuable translational platform for further mechanism research.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты